January 16, 2020 Columns by Tamara Sellman Need to Know: Blood Tests and Multiple Sclerosis Editor’s note: “Need to Knowā is a series inspired by common forum questions and comments from readers. Have a comment or question about MS? Visit our forum. This week’s question is inspired by the post “Is It a Multiple Sclerosis Diagnosis or Something Else?” from July 20, 2018.
November 15, 2019 Columns by Ed Tobias Is It Good that Google Is Crunching Our Healthcare Data? Google has quietly teamed up with Ascension, one of the largest healthcare organizations in the United States, to process the medical records of millions of people. According to The Wall Street Journal, “Project Nightingale” involves all sorts of information about things like lab results,Ā diagnoses, and hospitalization records, and…
July 26, 2018 News by Iqra Mumal, MSc Machine Learning Platform Can Accurately Predict Onset of MS, Maker Says IQuity, a data analytics company, announced the launch of an analytics platform that uses machine learning to predict, identify, and monitor chronic disease within large populations of patients, including multiple sclerosis (MS). The platform was validated using a pilot study that assessed the healthcare claims of 20 million people…
September 21, 2017 News by Patricia Silva, PhD IQuity Taking Orders for RNA-based Blood Test That Can Detect MS Early with 90% Accuracy The life science tech company IQuityĀ has begun taking orders from physicians for an RNA-based blood test that can provide reliable yes or no resultsĀ for multiple sclerosisĀ in seven days ā dramatically faster than previous options, which took months or years. The test, IsolateMS, can be a game-changer in…
June 15, 2017 News by Joana Fernandes, PhD IQuity Given $1M NIH Grant to Advance Research into RNA-based Diagnostic Tests for MS The National Institutes of Health (NIH) has awarded a $1 million grant to IQuity, a Nashville-based company looking into novel RNA targets that ultimately benefit patients with multiple sclerosis (MS) and other autoimmune disorders. The NIH grant is part of the institute’sĀ Small Business Innovation Research (SBIR) program.
March 9, 2017 News by Patricia Silva, PhD IQuity to Release 7-Day Blood Diagnostics Test for Multiple Sclerosis in May Molecular diagnostics startupĀ IQuity is introducing a pioneering blood test that speeds upĀ multiple sclerosis (MS) diagnosis to just seven days. Previously, this process could take up to months or years. IQuity, based in Nashville, Tennessee, began working on its new IsolateMS blood test in January 2016, after receiving $2…